[F-18] Fluciclatide Pet As A Biomarker Of Clinical Response To Combination Therapy Of Pazopanib And Paclitaxel In Patients With Platinum-Resistant Or Platinum-Refractory Advanced Ovarian Cancer: Results Of A Phase Ib Study.
JOURNAL OF CLINICAL ONCOLOGY（2019）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要